NYSE
COO

Cooper Companies Inc

Medical Instruments & Supplies
Healthcare

Prices are adjusted according to historical splits.

Cooper Companies Inc Stock Price

Vitals

Today's Low:
$347.185
Today's High:
$350.52
Open Price:
$350.52
52W Low:
$244.1936
52W High:
$395.2
Prev. Close:
$351.59
Volume:
232005

Company Statistics

Market Cap.:
$17.49 billion
Book Value:
145.527
Revenue TTM:
$3.38 billion
Operating Margin TTM:
0%
Gross Profit TTM:
$2.17 billion
Profit Margin:
0%
Return on Assets TTM:
3%
Return on Equity TTM:
5.26%

Company Profile

Cooper Companies Inc had its IPO on 1983-12-30 under the ticker symbol COO.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Cooper Companies Inc has a staff strength of 14,000 employees.

Stock update

Shares of Cooper Companies Inc opened at $350.52 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $347.19 - $350.52, and closed at $347.84.

This is a -1.07% slip from the previous day's closing price.

A total volume of 232,005 shares were traded at the close of the day’s session.

In the last one week, shares of Cooper Companies Inc have slipped by -4.62%.

Cooper Companies Inc's Key Ratios

Cooper Companies Inc has a market cap of $17.49 billion, indicating a price to book ratio of 2.1285 and a price to sales ratio of 4.8349.

In the last 12-months Cooper Companies Inc’s revenue was $3.38 billion with a gross profit of $2.17 billion and an EBITDA of $911.20 million. The EBITDA ratio measures Cooper Companies Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cooper Companies Inc’s operating margin was 0% while its return on assets stood at 3% with a return of equity of 5.26%.

In Q1.3333333333333, Cooper Companies Inc’s quarterly earnings growth was a negative -11% while revenue growth was a positive 9.1%.

Cooper Companies Inc’s PE and PEG Ratio

Forward PE
22.3214
Trailing PE
49.1042
PEG
2.015

Its diluted EPS in the last 12-months stands at $7.2 per share while it has a forward price to earnings multiple of 22.3214 and a PEG multiple of 2.015. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cooper Companies Inc’s profitability.

Cooper Companies Inc stock is trading at a EV to sales ratio of 5.4094 and a EV to EBITDA ratio of 25.1317. Its price to sales ratio in the trailing 12-months stood at 4.8349.

Cooper Companies Inc stock pays annual dividends of $0 per share, indicating a yield of 0.02% and a payout ratio of 0.5%.

Balance sheet and cash flow metrics

Total Assets
$11.54 billion
Total Liabilities
$949.10 million
Operating Cash Flow
$-82000000.00
Capital Expenditure
$73.60 million
Dividend Payout Ratio
0.5%

Cooper Companies Inc ended 2024 with $11.54 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $11.54 billion while shareholder equity stood at $7.38 billion.

Cooper Companies Inc ended 2024 with $139.00 million in deferred long-term liabilities, $949.10 million in other current liabilities, 5400000.00 in common stock, $6.71 billion in retained earnings and $3.66 billion in goodwill. Its cash balance stood at $111.90 million and cash and short-term investments were $111.90 million. The company’s total short-term debt was $74,500,000 while long-term debt stood at $2.57 billion.

Cooper Companies Inc’s total current assets stands at $1.60 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $564.70 million compared to accounts payable of $242.40 million and inventory worth $699.00 million.

In 2024, Cooper Companies Inc's operating cash flow was $-82000000.00 while its capital expenditure stood at $73.60 million.

Comparatively, Cooper Companies Inc paid $0.01 in dividends in 2024.

Other key metrics

Current Trading Price
$347.84
52-Week High
$395.2
52-Week Low
$244.1936
Analyst Target Price
$397.17

Cooper Companies Inc stock is currently trading at $347.84 per share. It touched a 52-week high of $395.2 and a 52-week low of $395.2. Analysts tracking the stock have a 12-month average target price of $397.17.

Its 50-day moving average was $378.29 and 200-day moving average was $359.18 The short ratio stood at 5.77 indicating a short percent outstanding of 0%.

Around 55.4% of the company’s stock are held by insiders while 10116.5% are held by institutions.

Frequently Asked Questions About Cooper Companies Inc

The stock symbol (also called stock or share ticker) of Cooper Companies Inc is COO

The IPO of Cooper Companies Inc took place on 1983-12-30

Similar Industry Stocks (Medical Instruments & Supplies)

Last Price
Chg
Chg%
$0.95
-0.06
-5.94%
$9.75
0.04
+0.42%
$4.18
0.19
+4.76%
$1484.15
-59.15
-3.83%
$0.04
0
0%
$3.44
-0.09
-2.55%
$1.81
-0.12
-6.22%
$12.61
-0.15
-1.18%
HIPOLIN LTD. (HIPOLIN)
$76.93
-3.06
-3.83%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Address

6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583